Atlas Trials

Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLC

Clinical trial NCT03644823 · TERMINATED

Trial details

NCT number
NCT03644823
Sponsor
Oslo University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2018-08-15
Primary completion
2020-12-31
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.